Valens (VLN)
:VLN
US Market
Advertisement

Valens (VLN) AI Stock Analysis

Compare
449 Followers

Top Page

VLN

Valens

(NYSE:VLN)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 4o)
Rating:51Neutral
Price Target:
$2.00
▲(25.00% Upside)
Valens' overall stock score is driven by its challenging financial performance and weak technical indicators. Despite positive earnings call sentiment and revenue growth, persistent losses and negative cash flows weigh heavily on the score. The valuation is also unattractive due to a negative P/E ratio and no dividend yield.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand in key markets, enhancing Valens' market position and supporting long-term expansion.
New Product Launches
Entering the medical imaging market with innovative products diversifies Valens' revenue streams and leverages its technology across industries.
Strategic Partnerships
Partnership with Samsung enhances Valens' position in automotive connectivity, promising advancements in ADAS and autonomous driving technologies.
Negative Factors
Negative Cash Flow
Persistent negative cash flow suggests operational inefficiencies, which could hinder Valens' ability to invest in growth and innovation.
Sustained Net Loss
Ongoing net losses reflect challenges in achieving profitability, which may impact Valens' financial stability and investor confidence.
Declining Cash Reserves
A decline in cash reserves limits financial flexibility, potentially affecting Valens' ability to fund strategic initiatives and manage risks.

Valens (VLN) vs. SPDR S&P 500 ETF (SPY)

Valens Business Overview & Revenue Model

Company DescriptionValens (VLN) is a leading provider of high-speed data connectivity solutions for the audio-visual, consumer electronics, and automotive industries. The company specializes in developing advanced semiconductor technologies that enable the seamless transmission of data over various mediums, including copper and fiber optics. Valens' core products include chipset solutions for HDMI, DisplayPort, and USB, as well as proprietary technologies for automotive applications, catering to the growing demand for high-resolution video and data integrity in modern electronics.
How the Company Makes MoneyValens generates revenue primarily through the sale of its semiconductor products, including integrated circuits and chipsets that facilitate high-speed data transmission. Key revenue streams include direct sales to manufacturers in the consumer electronics and automotive sectors, as well as licensing agreements for its proprietary technologies. The company also benefits from strategic partnerships with industry leaders, which enhance its market reach and provide opportunities for co-development of innovative solutions. Additionally, Valens may engage in the provision of technical support and consultancy services, further contributing to its earnings.

Valens Earnings Call Summary

Earnings Call Date:Nov 12, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Positive
The earnings call reflects a positive sentiment with significant revenue growth exceeding expectations, robust gross margins, and advancements in both the ProEV and medical segments. However, challenges include decreased automotive gross margins, a sustained net loss, and declining cash reserves.
Q3-2025 Updates
Positive Updates
Revenue Exceeds Expectations
Q3 2025 revenue was $17.3 million, significantly above the guidance range of $15.1 million to $15.6 million, marking the sixth consecutive quarter of growth.
Strong Gross Margin
GAAP gross margin for Q3 2025 was 63%, better than the guidance range and consistent with Q2 2025.
ProEV Segment Growth
Adoption of the VF3000 chipset continued to grow, emphasizing demand in the ProEV market.
Medical Innovations
Launch of the first V7000-based disposable colonoscopy with 4K video resolution, showcasing strong market fit and addressing industry trends.
Automotive Sector Developments
Multiple design wins with leading European OEMs for the MiPi A5 standard, strengthening the company's position in the automotive market.
Negative Updates
Cash and Cash Equivalents Decline
Cash, cash equivalents, and short-term deposits decreased to $93.5 million at the end of Q3 2025 from $102.7 million at the end of Q2 2025.
Decrease in Automotive Gross Margin
Automotive gross margin decreased to 43.2% in Q3 2025 from 50.5% in Q2 2025 due to product version mix and operational expenses related to manufacturing line transition.
GAAP Net Loss
GAAP net loss in Q3 2025 was $7.3 million, slightly more than the net loss of $7.2 million in Q2 2025.
Company Guidance
During the third quarter of 2025, Valens Semiconductor reported robust financial performance, exceeding its revenue expectations with $17.3 million, well above the guided range of $15.1 million to $15.6 million. This performance marked the sixth consecutive quarter of growth, largely driven by strong demand in the ProEV market. The GAAP gross margin was 63%, surpassing the anticipated 58% to 60%, while the adjusted EBITDA loss was $4.3 million, better than the forecasted loss range of $7.4 million to $6.8 million. Looking ahead to the fourth quarter, Valens projects revenue between $18.2 million and $18.9 million, and for the full year, expects total revenue to fall between $69.4 million and $70.1 million, reflecting approximately 20% growth over 2024. The continued expansion across various markets, including cross-industry business and automotive, alongside strategic product developments like the VF3000 and VA7000 chipsets, underpins Valens' optimistic outlook.

Valens Financial Statement Overview

Summary
Valens shows some positive signs such as revenue growth and low leverage, but persistent losses and negative cash flows highlight the need for operational improvements. The company must enhance profitability and cash flow generation to strengthen its financial position.
Income Statement
45
Neutral
Valens has shown a slight improvement in revenue growth with a TTM growth rate of 1.95%, but it still faces significant challenges with profitability. The gross profit margin remains healthy at 60.87%, indicating efficient production, but the net profit margin is negative at -49.80%, reflecting ongoing losses. EBIT and EBITDA margins are also negative, highlighting operational inefficiencies.
Balance Sheet
55
Neutral
The company's balance sheet shows a low debt-to-equity ratio of 0.07, indicating low leverage, which is a positive sign of financial stability. However, the return on equity is negative at -24.81%, suggesting that the company is not generating sufficient returns on shareholders' investments. The equity ratio is relatively strong, indicating a solid capital structure.
Cash Flow
50
Neutral
Valens has experienced a significant improvement in free cash flow growth at 98.89%, but the operating cash flow remains negative, which is concerning. The free cash flow to net income ratio is positive at 1.42, indicating that the company is generating cash relative to its net losses, but the negative operating cash flow to net income ratio suggests challenges in core operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue67.89M57.86M84.16M90.72M70.68M56.91M
Gross Profit42.41M34.28M52.59M63.39M50.58M43.48M
EBITDA-25.57M-33.91M-17.93M-25.86M-25.01M-18.36M
Net Income-30.13M-36.58M-19.66M-27.67M-26.53M-19.64M
Balance Sheet
Total Assets136.69M172.15M180.56M195.66M202.60M79.17M
Cash, Cash Equivalents and Short-Term Investments93.55M130.96M142.02M148.39M174.36M61.57M
Total Debt6.66M7.62M1.96M3.44M0.000.00
Total Liabilities27.86M29.46M16.25M28.22M20.40M161.39M
Stockholders Equity108.83M142.69M164.30M167.44M182.20M-82.22M
Cash Flow
Free Cash Flow-14.45M-848.00K-7.54M-23.20M-23.05M-20.47M
Operating Cash Flow-12.81M1.02M-6.36M-22.09M-21.61M-19.61M
Investing Cash Flow33.34M17.78M1.35M-11.73M-84.16M28.31M
Financing Cash Flow-23.78M-155.00K1.50M822.00K135.43M406.00K

Valens Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.60
Price Trends
50DMA
1.78
Negative
100DMA
2.08
Negative
200DMA
2.18
Negative
Market Momentum
MACD
-0.05
Positive
RSI
39.57
Neutral
STOCH
31.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VLN, the sentiment is Negative. The current price of 1.6 is below the 20-day moving average (MA) of 1.69, below the 50-day MA of 1.78, and below the 200-day MA of 2.18, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 39.57 is Neutral, neither overbought nor oversold. The STOCH value of 31.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VLN.

Valens Risk Analysis

Valens disclosed 62 risk factors in its most recent earnings report. Valens reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Valens Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
57
Neutral
$477.89M-12.00%-4.54%-119.39%
54
Neutral
$205.82M-0.91%-0.41%-134.49%
51
Neutral
$169.15M-23.56%7.53%-15.00%
48
Neutral
$101.63M-47.86%-20.20%-58.57%
44
Neutral
$84.56M-8.46%-7.79%10.04%
39
Underperform
$89.97M-4.20-116.86%-94.26%3.20%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VLN
Valens
1.52
-0.44
-22.45%
ASYS
Amtech Systems
7.14
1.33
22.89%
AXTI
AXT
9.90
8.07
440.98%
MX
MagnaChip
2.30
-1.34
-36.81%
ATOM
Atomera
2.19
-3.26
-59.82%
MRAM
Everspin Technologies
7.99
1.95
32.28%

Valens Corporate Events

Valens Semiconductor Reports Q3 2025 Financial Results
Nov 12, 2025

Valens Semiconductor Ltd. released its unaudited condensed consolidated interim financial statements for the nine months ending September 30, 2025. The company reported revenues of $51.2 million, a significant increase from $41.2 million in the same period in 2024, indicating growth in its operations. Despite the increase in revenues, the company continues to face a comprehensive loss, reflecting ongoing challenges in managing costs and achieving profitability. The financial results highlight Valens’ efforts to strengthen its market position and the potential implications for its stakeholders.

Valens Semiconductor Surpasses Q3 2025 Expectations and Appoints New CEO
Nov 12, 2025

Valens Semiconductor reported strong financial results for the third quarter of 2025, with revenues of $17.3 million, surpassing their guidance. The company experienced significant growth in the industrial machine vision and medical markets, with new product launches and partnerships enhancing their market position. The Board of Directors announced the appointment of Yoram Salinger as the new CEO, effective November 13, 2025, indicating a strategic move to further accelerate growth and strengthen Valens’ leadership in the connectivity industry.

Valens Semiconductor Announces Annual General Meeting for December 2025
Nov 10, 2025

Valens Semiconductor Ltd. has announced its upcoming Annual General Meeting of Shareholders scheduled for December 16, 2025. The meeting will address several key proposals, including the re-election of directors, approval of employment terms for the new CEO, and the re-appointment of the company’s accounting firm. The board recommends voting in favor of all proposals, which are crucial for the company’s governance and operational continuity.

Valens Semiconductor Enters Medical Imaging Market with VA7000-Powered Endoscopes
Nov 10, 2025

On November 10, 2025, Valens Semiconductor announced the launch of the first endoscopes using its VA7000 chipset by three OEMs, marking a significant entry into the medical imaging market. These products include a laparoscope, a 3D imaging solution for robotic surgeries, and a single-use colonoscope with 4K video resolution. The VA7000 chipset, known for its electrosurgical noise cancellation and high-resolution video capabilities, is repurposed from automotive to medical applications, showcasing Valens’ strategic expansion and strengthening its market position.

Valens Semiconductor Appoints Yoram Salinger as New CEO
Nov 3, 2025

Valens Semiconductor announced on November 3, 2025, the appointment of Yoram Salinger as the new CEO, effective November 13, 2025. Salinger, who has a strong track record in leading tech companies to growth, will succeed Gideon Ben-Zvi, who will remain on the board. Under Ben-Zvi’s leadership, Valens went public and expanded its market presence. Salinger’s leadership is expected to further accelerate Valens’ growth in high-performance connectivity across various industries. Additionally, changes in the board of directors were announced, with Dr. Eyal Kishon and Dror Jerushalmi stepping down.

Valens Semiconductor and Samsung Collaborate on MIPI A-PHY Standard
Sep 9, 2025

On September 9, 2025, Valens Semiconductor announced a partnership with Samsung to enhance the MIPI A-PHY standard ecosystem and develop next-generation products. This collaboration aims to meet the growing demand from global OEMs for advanced automotive connectivity solutions. Samsung’s support of the MIPI A-PHY standard and its advanced automotive process technology will bolster Valens’ position in the industry, promising significant advancements in ADAS and autonomous driving technologies.

Valens Semiconductor Appoints Igal Rotem to Board of Directors
Aug 26, 2025

On August 26, 2025, Valens Semiconductor announced the appointment of Igal Rotem to its Board of Directors, replacing Michael Linse, who served since 2018. Rotem, a seasoned high-tech executive and entrepreneur, is expected to bring valuable insights to Valens due to his extensive experience in scaling businesses and driving strategic growth, which aligns with Valens’ goals of expanding its technology leadership across various industries.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025